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Introduction

Antioch University (“AU” or the “University”) is committed to the development and
maintenance of an educational and workplace environment in compliance with the Drug- Free Schools
and Communities Act of 1989 and the Drug-Free Workplace Act of 1988, and does not permit the
unlawful possession, use, or distribution of illicit drugs and alcohol by students and employees on its
property or at any of its activities.
II.

Purpose
The purpose of the Drug-Free Schools and Communities policy is to:
1.

Maintain learning and working environments free from alcohol and drug abuse;

2.

Educate students and employees about the consequences of alcohol and drug abuse;

3.
Inform students and employees that Antioch University will not tolerate alcohol and
substance abuse in the learning and working environments, and to provide sanctions for
violations of the policy;
4.

Inform students and employees of the resources available to them to help address

alcohol and drug abuse; and
5.
Encourage students and employees with alcohol and/or drug abuse issues to get the
assistance that they need to resolve those issues.
III.

Policy
A.
Prohibitions. No student or employee may possess, use, transfer, distribute,
manufacture or attempt to manufacture, or traffic in illicit drugs or alcohol in violation of state
or federal law or attempt, solicit or conspire to commit any such offenses. This policy also
prohibits these activities with synthetic or counterfeit substances that are an analogue for a
controlled substance; the misuse, transfer, or sale of legal substances such as prescription
drugs; and the possession or use of drug paraphernalia.
B.
Federal Law Overrides Conflicting State or Local Laws. To remain eligible for federal
funding of various programs and grants, including student financial aid, the University complies
with all federal laws and regulations. Federal laws (including the Controlled Substances Act,
the Drug Free Schools and Communities Act, and the Drug Free Workplace Act) make it illegal
to possess, cultivate or sell marijuana. Thus, the University prohibits the cultivation,
possession, use, or distribution of marijuana, even for state certified medical purposes, at
University-sponsored events or activities and on University property. State or local laws that
legalize certain drug-related conduct do not affect University drug policy. It is important to
note that conviction for federal drug offences, including those related to marijuana, may result
in a student’s loss of eligibility for federal financial aid.
C.
Application. The Drug-Free Schools and Communities Policy applies to all University
campuses and extends to any worksite designated or used for the performance of work, any
vehicles used for University work, and at any University-sponsored activities, including practica
and internships.
D.
Condition of Enrollment and Employment. As a condition of enrollment at the
University, students are required to abide by this policy. Similarly, as a condition of
employment, employees are required to abide by this policy. Violation of this policy may
subject the violator to disciplinary action, including disenrollment or termination of
employment.

IV.

Risks Associated with Alcohol and Drug Abuse

Risks from alcohol and drug abuse are numerous and wide-ranging. They include physical and
mental impairment, emotional and psychological harm, and adverse effects on family and friends. The
health risks from alcohol abuse include anemia, cancer, cardiovascular disease, cirrhosis, dementia,
depression, gout, high blood pressure, infectious diseases, injuries to self and others, nerve damage,
pancreatitis, seizures and stroke, and death.
Drug abuse causes similar health risks. The universe of illicit drugs is large and varied, as are

the attendant risks. The National Institute on Drug Abuse compiles Common Drugs of Abuse charts,
which list the risks associated with particular drugs. Those charts, dated March 2015, are incorporated
and appended as Appendix A. For what may be more current information from the National Institute
on Drug Abuse, see the Common Drugs of Abuse charts at the National Institute on Drug Abuse
website: http://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs-charts-0.
An abuser of drugs and/or alcohol causes risks to self as well as to other students or co-workers
and the community, including accidents, decreased productivity, increased stress, and injuries.
Alcohol and other drug abuse can contribute to poor academic and/or job performance, poor social
interactions, unwanted sexual activity and sexually transmitted diseases, and can jeopardize career
prospects (e.g., admission to law school, government employment).
V.

Sanctions under Federal, State, and Local Law
A.
Cooperation with Law Enforcement. The University cooperates fully with law
enforcement authorities. The University may refer violations of this policy (and other
University policies including the Student Conduct Policy and Employee Conduct Policy) that are
also violations of federal, state or local law to the appropriate authorities. In such situations,
cases may proceed concurrently in the University system and in the criminal justice system.
B.
Sanctions. There are federal, state, and local sanctions for violations of drug and alcohol laws.
A listing of federal sanctions from the Drug Enforcement Agency (DEA) as of July 2015 is incorporated
by reference and appended as Appendix B and C. Listings of sanctions as of July 2015 from the states
of Ohio, New Hampshire, Washington, and California, including ordinances from the City of Los
Angeles are incorporated by reference and appended as Appendix D, E, F, and G respectively. As
sanctions for violations of drug and alcohol laws change regularly, it is the responsibility of students
and employees to ascertain if there are new or updated sanctions that may be relevant.
In addition, students should be aware that a conviction on a federal drug charge will
result in denial of federal benefits (including eligibility for federal financial aid) under 21 U.S.C.
§ 862.
C.
Marijuana Policy. It is important to note that some state or local laws may allow
marijuana use, possession, processing or distribution that is also prohibited under federal law.
Therefore, such drug-related conduct that is allowed under state law may also be prosecuted
under federal law. As a recipient of federal Title IV financial aid funds, Antioch University
prohibits all drug-related conduct that violates federal law on University campuses and in
University programs and activities, regardless of state or local laws.

VI.

Consequences of Policy Violation for Students

One of the goals of this policy is to encourage students to voluntarily seek help with alcohol
and/or drug problems. However, if an individual violates the policy, the consequences are serious.
Any student who violates this policy, and therefore also Student Conduct Policy, 6.103, is
subject to the process and sanctions outlined in the Student Conduct Policy. Those sanctions may

include, but are not limited to formal reprimand, required counseling or treatment, mandatory leave,
and disenrollment from the University.
In determining the appropriate sanction for violation of this policy, the University may, at a
minimum, consider the following circumstances:
1.

How the violation was committed;

2.

The amount and nature of the alcohol and/or drug(s) involved;

3.

The level of knowledge and intent of the student(s);

4.

Disruption to the learning and working environments; and

5.

Prior conduct of the student(s).

This list is not exhaustive and other circumstances may be considered when determining sanctions.
VII.

Employee Notice to University of Conviction

As a condition of employment and as required by federal law, any employee who is convicted
of unlawfully possessing, using, dispensing, distributing, or manufacturing any controlled substances
or illicit drugs within the workplace, must notify the local Human Resources Director in writing within
five (5) calendar days of the conviction.
If the employee is directly engaged in performance of work pursuant to the provisions of a
federal grant or federal contract, the University shall give notice of the conviction to the federal agency
with whom it has contracted or from whom it received the grant within ten (10) calendar days of
receiving notification of conviction.
VIII.

Consequences of Policy Violation for Employees

One of the goals of this policy is to encourage employees to voluntarily seek help with alcohol
and/or drug problems. However, if an individual violates the policy, the consequences are serious.
Upon determination of a violation of this policy or within thirty days after receiving notice of a
conviction, the University shall take appropriate disciplinary or referral action. Discipline for violating
this policy shall be governed by the University’s Corrective Action and Discipline Policy 4.617. Nothing
in this policy limits the right of the University under federal, state or local law to discipline the
employee, up to and including termination, for violation of any University policy or rule. In addition to
University discipline, civil or criminal penalties may apply including fines and/or incarceration
depending on federal, state or local law.
In lieu of or as part of any disciplinary sanctions for violation of this policy, the University in its
discretion may require the employee to satisfactorily participate in or complete alcohol or drug abuse

assistance or rehabilitation programs designated by the University and approved for such purposes by
a federal, state or local health, law enforcement, or other appropriate agency.
IX.

Drug and Alcohol Abuse Prevention Program

In support of the goals of this policy, the University shall maintain a drug and alcohol
abuse prevention program for all students and employees.
A.

Contents of Drug and Alcohol Abuse Prevention Program

The University shall maintain a drug and alcohol abuse prevention program to inform
all students and employees about this policy and:
1.
The University’s intent to maintain drug-free learning and working
environments;
2.

The risks of drug abuse in the learning and working environments;

3.
Drug or alcohol counseling, treatment, and rehabilitation/re-entry programs
that are available to students and employees;
4.

The employee assistance program; and

5.
Penalties that may be imposed for violation of this policy and a
description of the applicable legal sanctions under federal, state and local law for
the unlawful possession or distribution of illicit drugs and alcohol.

B.

Confidentiality

All information received by the University through the drug and alcohol abuse
prevention program is confidential. Access to this information is limited to those who have a
legitimate need to know in compliance with relevant laws and policies.
C.

Biennial Review of Drug and Alcohol Abuse Prevention Program

Pursuant to the Drug-Free Schools and Communities Act, the University shall conduct
a biennial review to determine the effectiveness of its drug and alcohol abuse prevention
program, and to ensure consistent enforcement of application drug and alcohol-related
statutes, ordinances, and University policies against students and employees found to be in
violation.
The University will maintain the biennial review materials to provide to the federal
Department of Education upon request.
D.

Disclosure of Drug Abuse and Alcohol Prevention Program

The University will disclose the provisions of its Drug Abuse and Alcohol Prevention
Program to all students and employees annually, along with its disclosure to students and

employees of the Annual Security Report under the Clery Act on or before October 1 each year.
For those individual students who enroll after October 1 and those individual employees who
are hired after October 1, the University will disclose its most recent Drug Abuse and Alcohol
Prevention Program materials as part of the students’ orientation materials and through the
Office of Human Resources upon hire, respectively.
X.

Student and Employee Assistance Programs

Students and employees who are struggling with alcohol or drugs are strongly encouraged to
seek assistance. Students may seek advice from their advisor, or the campus Student Services officer.
Each campus and program has information regarding inpatient and outpatient facilities,
recovery meetings, and counseling services in the vicinity of that campus. For students and employees
who live at a distance from campus, the University will provide relevant information to each person
who requests it.
The University’s Employee Assistance Program (EAP) is available free of charge to employees
and their families on a confidential basis. Employees who have a concern about drug or alcohol abuse
are strongly encouraged to contact the Office of Human Resources for assistance in finding the right
resources to address the issue.
XI.

Appendices
A.

Common Drugs of Abuse charts from the National Institute on Drug Abuse

B.

DEA Federal Penalty Chart 1

C.

DEA Federal Penalty Chart 2

D.

Ohio Drug and Alcohol Law Summary

E.

New Hampshire Drug and Alcohol Law Summary

F.

Washington State Drug and Alcohol Law Summary

G.

California and Los Angeles Drug and Alcohol Law Summary

Policy Cross Reference
This policy updates Policy 4.505, formerly entitled “Drug Free Workplace.”
Corrective Action and Discipline Procedure
Student Conduct
Employee Code of Conduct

Policy # 4.617
Policy # 6.103
Policy # 4.601

Common Drugs of Abuse
Most drugs of abuse are addictive. Addiction is a chronic, relapsing disease characterized by compulsive drug seeking
and use despite negative consequences and by long-lasting changes in the brain. People who are addicted have strong
cravings for the drug, making it difficult to stop using. Most drugs alter a person’s thinking and judgment, which can
increase the risk of injury or death from drugged driving or infectious diseases (e.g., HIV/AIDS, hepatitis) from unsafe
sexual practices or needle sharing. Drug use during pregnancy can lead to neonatal abstinence syndrome, a condition in
which a baby can suffer from dependence and withdrawal symptoms after birth. Pregnancy-related issues are listed in
the chart below for drugs where there is enough scientific evidence to connect the drug use to negative effects.
However, most drugs could potentially harm an unborn baby.
In the chart, the Drug Enforcement Agency (DEA) schedule indicates the drug’s acceptable medical use and its potential
for abuse or dependence. More information can be found on the DEA website. For more comprehensive information
about treatment options for drug addiction, see NIDA’s Principles of Drug Addiction Treatment: A Research-Based Guide
(Third Edition).
The following drugs are included in this resource:









Alcohol
Ayahuasca
Bath Salts (Synthetic Cathiones)
Cocaine
DMT
GHB
Hallucinogens
Heroin

 Inhalants
 Ketamine
 LSD
 Marijuana (Cannabis)
 MDMA (Ecstasy/Molly)

 Mescaline (Peyote)
 Methamphetamine






Over-the-counter Cough/Cold Medicines (Dextromethorphan or DMX)
PCP
Prescription Opioids
Prescription Sedatives
Prescription Stimulants







Psilocybin
Salvia
Steroids (Anabolic)
Synthetic Cannabinoids (“K2” / “Spice”)
Tobacco

Alcohol
People drink to socialize, celebrate, and relax. Alcohol often has a strong effect on people – and throughout
history, people have struggled to understand and manage alcohol’s power. Why does alcohol cause people to act and
feel differently? How much is too much? Why do some people become addicted while others do not? The National
Institute on Alcohol Abuse and Alcoholism is researching the answers to these, and many other questions about
alcohol. Here’s what is known:
Alcohol’s effects vary from person to person, depending on a variety of factors, including:
 How much you drink
 How often you drink
 Your age
 Your health status
 Your family history
While drinking alcohol is itself not necessarily a problem – drinking too much can cause a range of consequences, and
increase your risk for a variety of problems. For more information on alcohol’s effects on the body, please see
the National Institute on Alcohol Abuse and Alcoholism’s related web page describing alcohol’s effects on the body.

National Institute on Drug Abuse
Common Drugs of Abuse
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Ayahuasca
A hallucinogenic tea made in the Amazon from a DMT-containing plant (Psychotria viridis or Diplopterys cabrerana or
other) along with another vine (Banisteriopsis caapi) that contains an MAO Inhibitor preventing the natural
breakdown of DMT in the digestive system, thereby facilitating a prolonged hallucinatory experience. It was used
historically in Amazonian religious and healing rituals and is increasingly used by tourists. For more information, see
the Hallucinogens and Dissociative Drugs Research Report.
Street Names
Aya, Yagé, Hoasca

Commercial Names
No commercial uses

Common Forms
Brewed as tea

Common Ways Taken
Swallowed as tea

DEA
Schedule
DMT is
Schedule I
but plants
containin
g it are
not
controlled

Possible Health Effects
Short-term

Strong hallucinations including perceptions of otherworldly imagery, altered visual and
auditory perceptions; increased blood pressure, vomiting.

Long-term

Unknown.

Other Health-related
Issues

Unknown.

In Combination with
Alcohol

Unknown.

Withdrawal
symptoms

Unknown.
Treatment Options

Medications

It is not known whether ayahuasca is addictive. There are no FDA-approved medications to
treat addiction to ayahuasca or other hallucinogens.

Behavioral Therapies

More research is needed to find out if ayahuasca is addictive and, if so, whether behavioral
therapies are effective.

National Institute on Drug Abuse
Common Drugs of Abuse
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Bath Salts (Synthetic Cathinones)
An emerging family of drugs containing one or more synthetic chemicals related to cathinone, a stimulant found
naturally in the Khat plant. Examples of such chemicals include mephedrone, methylone, and 3,4methylenedioxypyrovalerone (MDPV). For more information, see the Bath Salts DrugFacts.
Street Names
Bloom, Cloud Nine,
Cosmic Blast, Ivory
Wave, Lunar Wave,
Scarface, Vanilla Sky,
White Lightning

Commercial Names
No commercial uses
for ingested “bath
salts”

Common Forms

Common Ways
Taken

DEA
Schedule

White or brown crystalline
powder sold in small plastic
or foil packages labeled “not
for human consumption” and
sometimes sold as jewelry
cleaner; tablet, capsule,
liquid

Swallowed, snorted,
injected

I
Some
formulatio
ns have
been
banned by
the DEA

Possible Health Effects
Short-term

Increased heart rate and blood pressure; euphoria; increased sociability and sex drive;
paranoia, agitation, and hallucinations; psychotic and violent behavior; nosebleeds;
sweating; nausea, vomiting; insomnia; irritability; dizziness; depression; suicidal thoughts;
panic attacks; reduced motor control; cloudy thinking.

Long-term

Breakdown of skeletal muscle tissue; kidney failure; death.

Other Health-related
Issues

Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Unknown.

Withdrawal
Symptoms

Depression, anxiety, problems sleeping, tremors, paranoia.
Treatment Options

Medications
Behavioral Therapies

There are no FDA-approved medications to treat addiction to bath salts.





National Institute on Drug Abuse
Common Drugs of Abuse

Cognitive-behavioral therapy (CBT)
Contingency management, or motivational incentives
Motivational Enhancement Therapy (MET)
Behavioral treatments geared to teens
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Cocaine
A powerfully addictive stimulant drug made from the leaves of the coca plant native to South America. For more
information, see the Cocaine Research Report.
Street Names

Commercial Names

Common Forms

Blow, Bump, C, Candy,
Charlie, Coke, Crack,
Flake, Rock, Snow,
Toot

Cocaine hydrochloride
topical solution
(anesthetic rarely used
in medical procedures)

White powder, whitish rock
crystal

Common Ways
Taken
Snorted, smoked,
injected

DEA
Schedule
II

Possible Health Effects
Short-term

Narrowed blood vessels; enlarged pupils; increased body temperature, heart rate, and blood
pressure; headache; abdominal pain and nausea; euphoria; increased energy, alertness;
insomnia, restlessness; anxiety; erratic and violent behavior, panic attacks, paranoia,
psychosis; heart rhythm problems, heart attack; stroke, seizure, coma.

Long-term

Loss of sense of smell, nosebleeds, nasal damage and trouble swallowing from snorting;
infection and death of bowel tissue from decreased blood flow; poor nutrition and weight
loss from decreased appetite.

Other Health-related
Issues

Pregnancy: premature delivery, low birth weight, neonatal abstinence syndrome.
Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Greater risk of overdose and sudden death than from either drug alone.

Withdrawal
Symptoms

Depression, tiredness, increased appetite, insomnia, vivid unpleasant dreams, slowed
thinking and movement, restlessness.
Treatment Options

Medications
Behavioral Therapies

There are no FDA-approved medications to treat cocaine addiction.




Cognitive-behavioral therapy (CBT)
Community reinforcement approach plus vouchers
Contingency management, or motivational incentives
The matrix model



12-Step facilitation therapy




National Institute on Drug Abuse
Common Drugs of Abuse
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DMT
A synthetic drug producing intense but relatively short-lived hallucinogenic experiences; also naturally occurring in
some South American plants (See Ayahuasca). For more information, see the Hallucinogens and Dissociative Drugs
Research Report.
Street Names
DMT, Dimitri

Commercial Names
No commercial uses

Common Forms
White or yellow
crystalline powder

Common Ways Taken

DEA
Schedule

Smoked, injected

I

Possible Health Effects
Short-term

Intense visual hallucinations, depersonalization, auditory distortions, and an altered
perception of time and body image, usually resolving in 30-45 minutes or less. Physical
effects include hypertension, increased heart rate, agitation, seizures, dilated pupils,
involuntary rapid eye movements, dizziness, incoordination.

Long-term

Unknown

Other Health-related
Issues

At high doses, coma and respiratory arrest have occurred.

In Combination with
Alcohol

Unknown.

Withdrawal
symptoms

Unknown.
Treatment Options

Medications

It is not known whether DMT is addictive. There are no FDA-approved medications to treat
addiction to DMT or other hallucinogens.

Behavioral Therapies

More research is needed to find out if DMT is addictive and, if so, whether behavioral
therapies are effective.

National Institute on Drug Abuse
Common Drugs of Abuse
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GHB
A depressant approved for use in the treatment of narcolepsy, a disorder that causes daytime “sleep attacks.” For
more information, see the Club Drugs DrugFacts.
Street Names
G, Georgia Home Boy,
Goop, Grievous Bodily
Harm, Liquid Ecstasy,
Liquid X, Soap, Scoop

Commercial Names
Gammahydroxybutyrate or
sodium oxybate
(Xyrem®)

Common Forms
Colorless liquid, white
powder

Common Ways
Taken

DEA
Schedule

Swallowed (often
combined with
alcohol or other
beverages)

I

Possible Health Effects
Short-term

Euphoria, drowsiness, decreased anxiety, confusion, memory loss, hallucinations, excited
and aggressive behavior, nausea, vomiting, unconsciousness, seizures, slowed heart rate and
breathing, lower body temperature, coma, death.

Long-term

Unknown.

Other Health-related
Issues

Sometimes used as a date rape drug.

In Combination with
Alcohol

Nausea, problems with breathing, greatly increased depressant effects.

Withdrawal
Symptoms

Insomnia, anxiety, tremors, sweating, increased heart rate and blood pressure, psychotic
thoughts.
Treatment Options

Medications

Benzodiazepines

Behavioral Therapies

More research is needed to find out if behavioral therapies can be used to treat GHB
addiction.

Hallucinogens
Drugs that cause profound distortions in a person’s perceptions of reality, such as ketamine, LSD, mescaline (peyote),
PCP, psilocybin, salvia, DMT, and ayahuasca. For more information, see the Hallucinogens and Dissociative Drugs
Research Report.

National Institute on Drug Abuse
Common Drugs of Abuse
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Heroin
An opioid drug made from morphine, a natural substance extracted from the seed pod of the Asian opium poppy
plant. For more information, see the Heroin Research Report.
Street Names
Brown sugar, China
White, Dope, H, Horse,
Junk, Skag, Skunk,
Smack, White Horse
With OTC cold
medicine and
antihistamine: Cheese

Commercial Names
No commercial uses

Common Forms
White or brownish
powder, or black sticky
substance known as
“black tar heroin”

Common Ways Taken
Injected, smoked,
snorted

DEA
Schedule
I

Possible Health Effects
Short-term

Long-term
Other Health-related
Issues

Euphoria; warm flushing of skin; dry mouth; heavy feeling in the hands and feet; clouded
thinking; alternate wakeful and drowsy states; itching; nausea; vomiting; slowed breathing
and heart rate.
Collapsed veins; abscesses (swollen tissue with pus); infection of the lining and valves in the
heart; constipation and stomach cramps; liver or kidney disease; pneumonia.
Pregnancy: miscarriage, low birth weight, neonatal abstinence syndrome.
Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Dangerous slowdown of heart rate and breathing, coma, death.

Withdrawal
Symptoms

Restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, cold flashes with goose
bumps ("cold turkey"), leg movements.
Treatment Options

Medications





Behavioral Therapies




National Institute on Drug Abuse
Common Drugs of Abuse

Methadone
Buprenorphine
Naltrexone (short and long-acting forms)
Contingency management, or motivational incentives
12-Step facilitation therapy
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Inhalants
Solvents, aerosols, and gases found in household products such as spray paints, markers, glues, and cleaning fluids;
also nitrites (e.g., amyl nitrite), which are prescription medications for chest pain. For more information, see the
Inhalants Research Report.
Street Names

Commercial Names

Poppers, snappers,
Various
whippets, laughing gas

Short-term

Common Forms
Paint thinners or removers,
degreasers, dry-cleaning
fluids, gasoline, lighter fluids,
correction fluids, permanent
markers, electronics cleaners
and freeze sprays, glue, spray
paint, hair or deodorant
sprays, fabric protector
sprays, aerosol computer
cleaning products, vegetable
oil sprays, butane lighters,
propane tanks, whipped
cream aerosol containers,
refrigerant gases, ether,
chloroform, halothane,
nitrous oxide

Common Ways
Taken
Inhaled through the
nose or mouth

DEA
Schedule
Not
scheduled

Possible Health Effects
Confusion; nausea; slurred speech; lack of coordination; euphoria; dizziness; drowsiness;
disinhibition, lightheadedness, hallucinations/delusions; headaches; sudden sniffing death
due to heart failure (from butane, propane, and other chemicals in aerosols); death from
asphyxiation, suffocation, convulsions or seizures, coma, or choking.
Nitrites: enlarged blood vessels, enhanced sexual pleasure, increased heart rate, brief
sensation of heat and excitement, dizziness, headache.

Long-term

Liver and kidney damage; bone marrow damage; limb spasms due to nerve damage; brain
damage from lack of oxygen that can cause problems with thinking, movement, vision, and
hearing.
Nitrites: increased risk of pneumonia.

Other Health-related
Issues

Pregnancy: low birth weight, bone problems, delayed behavioral development due to brain
problems, altered metabolism and body composition.

In Combination with
Alcohol

Nitrites: dangerously low blood pressure.

Withdrawal
Symptoms

Nausea, loss of appetite, sweating, tics, problems sleeping, and mood changes.
Treatment Options

Medications

There are no FDA-approved medications to treat inhalant addiction.

Behavioral Therapies

More research is needed to find out if behavioral therapies can be used to treat inhalant
addiction.

National Institute on Drug Abuse
Common Drugs of Abuse
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Ketamine
A dissociative drug used as an anesthetic in veterinary practice. Dissociative drugs are hallucinogens that cause the
user to feel detached from reality. For more information, see the Hallucinogens and Dissociative Drugs Research
Report.
Street Names
Cat Valium, K, Special
K, Vitamin K

Commercial Names
Ketalar®

Common Forms
Liquid, white powder

Common Ways Taken

DEA
Schedule

Injected , snorted,
smoked (powder
added to tobacco or
marijuana cigarettes),
swallowed

III

Possible Health Effects
Short-term

Problems with attention, learning, and memory; dreamlike states, hallucinations; sedation;
confusion and problems speaking; loss of memory; problems moving, to the point of being
immobile; raised blood pressure; unconsciousness; slowed breathing that can lead to death.

Long-term

Ulcers and pain in the bladder; kidney problems; stomach pain; depression; poor memory.

Other Health-related
Issues

Sometimes used as a date rape drug.
Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Increased risk of adverse effects.

Withdrawal
Symptoms

Unknown.
Treatment Options

Medications

There are no FDA-approved medications to treat addiction to ketamine or other dissociative
drugs.

Behavioral Therapies

More research is needed to find out if behavioral therapies can be used to treat addiction to
dissociative drugs.

National Institute on Drug Abuse
Common Drugs of Abuse
March 2015
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LSD
A hallucinogen manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains.
LSD is an abbreviation of the scientific name, lysergic acid diethylamide. For more information, see the Hallucinogens
and Dissociative Drugs Research Report.
Street Names

Commercial Names

Acid, Blotter, Blue
Heaven, Cubes,
Microdot, Yellow
Sunshine

No commercial uses

Common Forms
Tablet; capsule; clear liquid;
small, decorated squares of
absorbent paper that liquid
has been added to

Common Ways
Taken

DEA
Schedule

Swallowed, absorbed
through mouth
tissues (paper
squares)

I

Possible Health Effects
Short-term

Long-term

Rapid emotional swings; distortion of a person’s ability to recognize reality, think rationally,
or communicate with others; raised blood pressure, heart rate, body temperature; dizziness
and insomnia; loss of appetite; dry mouth; sweating; numbness; weakness; tremors;
enlarged pupils.
Frightening flashbacks (called Hallucinogen Persisting Perception Disorder ([HPPD]); ongoing
visual disturbances, disorganized thinking, paranoia, and mood swings.

Other Health-related
Issues

Unknown.

In Combination with
Alcohol

May decrease the perceived effects of alcohol.

Withdrawal
Symptoms

Unknown.
Treatment Options

Medications
Behavioral Therapies

National Institute on Drug Abuse
Common Drugs of Abuse
March 2015

There are no FDA-approved medications to treat addiction to LSD or other hallucinogens.
More research is needed to find out if behavioral therapies can be used to treat addiction to
hallucinogens.
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Marijuana (Cannabis)
Marijuana is made from the hemp plant, Cannabis sativa. The main psychoactive (mind-altering) chemical in
marijuana is delta-9-tetrahydrocannabinol, or THC. For more information, see the Marijuana Research Report.
Street Names

Commercial Names

Common Forms

Common Ways Taken

DEA
Schedule

Blunt, Bud, Dope,
Ganja, Grass, Green,
Herb, Joint, Mary
Jane, Pot, Reefer,
Sinsemilla, Skunk,
Smoke, Trees, Weed;
Hashish: Boom,
Gangster, Hash, Hemp

Various brand names in
states where the sale
of marijuana is legal

Greenish-gray mixture of
dried, shredded leaves,
stems, seeds, and/or
flowers; resin (hashish) or
sticky, black liquid (hash
oil)

Smoked, eaten (mixed in
food or brewed as tea)

I

Possible Health Effects
Short-term

Enhanced sensory perception and euphoria followed by drowsiness/relaxation; slowed
reaction time; problems with balance and coordination; increased heart rate and appetite;
problems with learning and memory; hallucinations; anxiety; panic attacks; psychosis.

Long-term

Mental health problems; chronic cough; frequent respiratory infections.

Other Health-related
Issues

Youth: possible loss of IQ points when repeated use begins in adolescence.
Pregnancy: babies born with problems with attention, memory, and problem solving.

In Combination with
Alcohol

Increased heart rate, blood pressure; further slowing of mental processing and reaction
time.

Withdrawal
Symptoms

Irritability, trouble sleeping, decreased appetite, anxiety.
Treatment Options

Medications
Behavioral Therapies

There are no FDA-approved medications to treat marijuana addiction.
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Cognitive-behavioral therapy (CBT)
Contingency management, or motivational incentives
Motivational Enhancement Therapy (MET)
Behavioral treatments geared to adolescents
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MDMA (Ecstasy/Molly)
A synthetic, psychoactive drug that has similarities to both the stimulant amphetamine and the hallucinogen
mescaline. MDMA is an abbreviation of the scientific name, 3,4-methylenedioxy-methamphetamine. For more
information, see the MDMA (Ecstasy) Abuse Research Report.
Street Names
Adam, Clarity, Eve,
Lover's Speed, Peace,
Uppers

Commercial Names
No commercial uses

Common Forms
Colorful tablets with
imprinted logos,
capsules, powder, liquid

Common Ways Taken

DEA
Schedule

Swallowed, snorted

I

Possible Health Effects
Short-term

Lowered inhibition; enhanced sensory perception; confusion; depression; sleep problems;
anxiety; increased heart rate and blood pressure; muscle tension; teeth clenching; nausea;
blurred vision; faintness; chills or sweating; sharp rise in body temperature leading to liver,
kidney, or heart failure and death.

Long-term

Long-lasting confusion, depression, problems with attention, memory, and sleep; increased
anxiety, impulsiveness, aggression; loss of appetite; less interest in sex.

Other Health-related
Issues

Unknown.

In Combination with
Alcohol

May increase the risk of cell and organ damage.

Withdrawal
Symptoms

Fatigue, loss of appetite, depression, trouble concentrating.

Medications
Behavioral Therapies

National Institute on Drug Abuse
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Treatment Options
There is conflicting evidence about whether MDMA is addictive. There are no FDA-approved
medications to treat MDMA addiction.
More research is needed to find out if behavioral therapies can be used to treat MDMA
addiction.
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Mescaline (Peyote)
A hallucinogen found in disk-shaped “buttons” in the crown of several cacti, including peyote. For more information,
see the Hallucinogens – LSD, Peyote, Psilocybin, and PCP DrugFacts.
Street Names
Buttons, Cactus, Mesc

Commercial Names
No commercial uses

Common Forms
Fresh or dried buttons,
capsule

Common Ways
Taken
Swallowed (chewed
or soaked in water
and drunk)

DEA
Schedule
I

Possible Health Effects
Short-term

Enhanced perception and feeling; hallucinations; euphoria; anxiety; increased body
temperature, heart rate, blood pressure; sweating; problems with movement.

Long-term

Unknown.

Other Health-related
Issues

Unknown.

In Combination with
Alcohol

Unknown.

Withdrawal
Symptoms

Unknown.
Treatment Options

Medications

There are no FDA-approved medications to treat addiction to mescaline or other
hallucinogens.

Behavioral Therapies

More research is needed to find out if behavioral therapies can be used to treat addiction to
hallucinogens.
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Methamphetamine
An extremely addictive stimulant amphetamine drug. For more information, see the Methamphetamine Research
Report.
Street Names
Crank, Chalk, Crystal,
Fire, Glass, Go Fast,
Ice, Meth, Speed

Commercial Names
Desoxyn®

Common Forms
White powder or pill;
crystal meth looks like
pieces of glass or shiny
blue-white “rocks” of
different sizes

Common Ways Taken

DEA
Schedule

Swallowed, snorted,
smoked, injected

II

Possible Health Effects
Short-term

Increased wakefulness and physical activity; decreased appetite; increased breathing, heart
rate, blood pressure, temperature; irregular heart beat.

Long-term

Anxiety, confusion, insomnia, mood problems, violent behavior; paranoia, hallucinations,
delusions, weight loss, severe dental problems (“meth mouth”), intense itching leading to
skin sores from scratching.

Other Health-related
Issues

Pregnancy: premature delivery; separation of the placenta from the uterus; low birth
weight; lethargy; heart and brain problems.
Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Masks the depressant effect of alcohol, increasing risk of alcohol overdose; may increase
blood pressure and jitters.

Withdrawal
Symptoms

Depression, anxiety, tiredness.
Treatment Options

Medications
Behavioral Therapies

There are no FDA-approved medications to treat methamphetamine addiction.
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Cognitive-behavioral therapy (CBT)
Contingency management or motivational incentives
The matrix model
12-Step facilitation therapy
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Over-the-counter Cough/Cold Medicines (Dextromethorphan or DMX)
Psychoactive when taken in higher-than-recommended amounts. For more information, see the Cough and Cold
Medicine Abuse DrugFacts.
Street Names
Robotripping, Robo,
Triple C

Commercial Names
Various (many brand
names include “DM”)

Common Forms
Syrup, capsule

Common Ways Taken
Swallowed

DEA
Schedule
Not
scheduled

Possible Health Effects
Short-term

Euphoria; slurred speech; increased heart rate, blood pressure, temperature; numbness;
dizziness; nausea; vomiting; confusion; paranoia; altered visual perceptions; problems with
movement; buildup of excess acid in body fluids.

Long-term

Unknown.

Other Health-related
Issues

Breathing problems, seizures, and increased heart rate may occur from other ingredients in
cough/cold medicines.

In Combination with
Alcohol

Increased risk of adverse effects.

Withdrawal
Symptoms

Unknown.
Treatment Options

Medications

There are no FDA-approved medications to treat addiction to over-the-counter cough/cold
medicines.

Behavioral Therapies

More research is needed to find out if behavioral therapies can be used to treat addiction to
over-the-counter cough/cold medicines.
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PCP
A dissociative drug developed as an intravenous anesthetic that has been discontinued due to serious adverse effects.
Dissociative drugs are hallucinogens that cause the user to feel detached from reality. PCP is an abbreviation of the
scientific name, phencyclidine. For more information, see the Hallucinogens and Dissociative Drugs Research Report.
Street Names
Angel Dust, Boat, Hog,
Love Boat, Peace Pill

Commercial Names

Common Forms

No commercial uses

White or colored powder,
tablet, or capsule; clear liquid

Common Ways
Taken

DEA
Schedule

Injected, snorted,
swallowed, smoked
(powder added to
mint, parsley,
oregano, or
marijuana)

I, II

Possible Health Effects
Short-term

Delusions, hallucinations, paranoia, problems thinking, a sense of distance from one’s
environment, anxiety.
Low doses: slight increase in breathing rate; increased blood pressure and heart rate;
shallow breathing; face redness and sweating; numbness of the hands or feet; problems
with movement.
High doses: lowered blood pressure, pulse rate, breathing rate; nausea; vomiting, blurred
vision; flicking up and down of the eyes; drooling; loss of balance; dizziness; violence;
suicidal thoughts; seizures, coma, and death.

Long-term

Memory loss, problems with speech and thinking, depression, weight loss, anxiety.

Other Health-related
Issues

PCP has been linked to self-injury.
Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Increased risk of coma.

Withdrawal
Symptoms

Headaches, sweating.
Treatment Options

Medications

There are no FDA-approved medications to treat addiction to PCP or other dissociative
drugs.

Behavioral Therapies

More research is needed to find out if behavioral therapies can be used to treat addiction to
dissociative drugs.

National Institute on Drug Abuse
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Prescription Opioids
Pain relievers with an origin similar to that of heroin. Opioids can cause euphoria and are often used nonmedically,
leading to overdose deaths. For more information, see the Prescription Drug Abuse Research Report.
Street Names

Commercial Names
(Common)

Captain Cody, Cody,
Lean, Schoolboy,
Sizzurp, Purple Drank
With glutethimide:
Doors & Fours, Loads,
Pancakes and Syrup

Codeine (various brand
names)

Tablet, capsule, liquid

Injected, swallowed
(often mixed with soda
and flavorings)

Apache, China Girl,
China White, Dance
Fever, Friend,
Goodfella, Jackpot,
Murder 8, Tango and
Cash, TNT

Fentanyl (Actiq®,
Duragesic®,
Sublimaze®)

Lozenge, sublingual
tablet, film, buccal tablet

Injected, smoked,
snorted

II

Vike, Watson-387

Hydrocodone or
dihydrocodeinone
(Vicodin®, Lortab®,
Lorcet®, and others)

Capsule, liquid, tablet

Swallowed, snorted,
injected

II

D, Dillies, Footballs,
Juice, Smack

Hydromorphone
(Dilaudid®)

Liquid, suppository

Injected, rectal

II

Demmies, Pain Killer

Meperidine (Demerol®)

Tablet, liquid

Swallowed, snorted,
injected

II

Amidone, Fizzies
With MDMA:
Chocolate Chip
Cookies

Methadone
(Dolophine®,
Methadose®)

Tablet, dispersible tablet,
liquid

Swallowed, injected

II

M, Miss Emma,
Monkey, White Stuff

Morphine
(Duramorph®,
Roxanol®)

Tablet, liquid, capsule,
suppository

Injected, swallowed,
smoked

II, III

O.C., Oxycet,
Oxycotton, Oxy,
Hillbilly Heroin, Percs

Oxycodone
(OxyContin®,
Percodan®, Percocet®,
and others)

Capsule, liquid, tablet

Swallowed, snorted,
injected

II

Biscuits, Blue Heaven,
Blues, Mrs. O, O
Bomb, Octagons, Stop
Signs

Oxymorphone
(Opana®)

Tablet

Swallowed, snorted,
injected

II

National Institute on Drug Abuse
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Common Forms

Common Ways Taken
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DEA
Schedule
II, III, V

Possible Health Effects
Short-term

Pain relief, drowsiness, nausea, constipation, euphoria, confusion, slowed breathing, death.

Long-term

Unknown.

Other Health-related
Issues

Pregnancy: Miscarriage; low birth weight; neonatal abstinence syndrome.
Older Adults: Higher risk of accidental misuse or abuse because many older adults have
multiple prescriptions, increasing the risk of drug-drug interactions, and breakdown of drugs
slows with age; also, many older adults are treated with prescription medications for pain.
Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Dangerous slowing of heart rate and breathing leading to coma or death.

Withdrawal
Symptoms

Restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, cold flashes with goose
bumps ("cold turkey"), leg movements.
Treatment Options

Medications





Behavioral Therapies

National Institute on Drug Abuse
Common Drugs of Abuse
March 2015

Methadone
Buprenorphine
Naltrexone (short- and long-acting)

Behavioral therapies that have helped treat addiction to heroin may be useful in treating
prescription opioid addiction.
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Prescription Sedatives (tranquilizers, depressants)
Medications that slow brain activity, which makes them useful for treating anxiety and sleep problems. For more
information, see the Prescription Drug Abuse Research Report.
Street Names

Commercial Names
(Common)

Common Forms

Common Ways Taken

DEA
Schedule

Barbs, Phennies, Red
Birds, Reds, Tooies,
Yellow Jackets,
Yellows

Barbiturates:
pentobarbital
(Nembutal®),
phenobarbital
(Luminal®)

Pill, capsule, liquid

Swallowed, injected

II, III, IV

Candy, Downers,
Sleeping Pills, Tranks

Benzodiazepines:
alprazolam (Xanax®),
chlorodiazepoxide
(Limbitrol®), diazepam
(Valium®), lorazepam
(Ativan®), triazolam
(Halicon®)

Pill, capsule, liquid

Swallowed, snorted

IV

Forget-me Pill,
Mexican Valium, R2,
Roche, Roofies,
Roofinol, Rope,
Rophies

Sleep Medications:
eszopiclone (Lunesta®),
zaleplon (Sonata®),
zolpidem (Ambien®)

Pill, capsule, liquid

Swallowed, snorted

IV

Possible Health Effects
Short-term

Drowsiness, slurred speech, poor concentration, confusion, dizziness, problems with
movement and memory, lowered blood pressure, slowed breathing.

Long-term

Unknown.

Other Health-related
Issues

Sleep medications are sometimes used as date rape drugs.
Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Further slows heart rate and breathing, which can lead to death.

Withdrawal
Symptoms

Must be discussed with a health care provider; barbiturate withdrawal can cause a serious
abstinence syndrome that may even include seizures.
Treatment Options

Medications

There are no FDA-approved medications to treat addiction to prescription sedatives;
lowering the dose over time must be done with the help of a health care provider.

Behavioral Therapies

More research is needed to find out if behavioral therapies can be used to treat addiction to
prescription sedatives.
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Prescription Stimulants
Medications that increase alertness, attention, energy, blood pressure, heart rate, and breathing rate. For more
information, see the Prescription Drug Abuse Research Report.
Street Names

Commercial Names
(Common)

Common Forms

Common Ways Taken

DEA
Schedule

Bennies, Black
Beauties, Crosses,
Hearts, LA
Turnaround, Speed,
Truck Drivers, Uppers

Amphetamine
(Adderall®,
Benzedrine®)

Tablet, capsule

Swallowed, snorted,
smoked, injected

II

JIF, MPH, R-ball,
Skippy, The Smart
Drug, Vitamin R

Methylphenidate
(Concerta®, Ritalin®)

Liquid, tablet, chewable
tablet, capsule

Swallowed, snorted,
smoked, injected,
chewed

II

Possible Health Effects
Short-term

Increased alertness, attention, energy; increased blood pressure and heart rate; narrowed
blood vessels; increased blood sugar; opened up breathing passages.
High doses: dangerously high body temperature and irregular heartbeat; heart failure;
seizures.

Long-term

Heart problems, psychosis, anger, paranoia.

Other Health-related
Issues

Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Masks the depressant action of alcohol, increasing risk of alcohol overdose; may increase
blood pressure and jitters.

Withdrawal
Symptoms

Depression, tiredness, sleep problems.
Treatment Options

Medications

There are no FDA-approved medications to treat stimulant addiction.

Behavioral Therapies

Behavioral therapies that have helped treat addiction to cocaine or methamphetamine may
be useful in treating prescription stimulant addiction.

National Institute on Drug Abuse
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Psilocybin
A hallucinogen in certain types of mushrooms that grow in parts of South America, Mexico, and the United States. For
more information, see the Hallucinogens and Dissociative Drugs Research Report.
Street Names
Little Smoke, Magic
Mushrooms, Purple
Passion, Shrooms

Commercial Names
No commercial uses

Common Forms

Common Ways Taken

DEA
Schedule

Fresh or dried
mushrooms with long,
slender stems topped by
caps with dark gills

Swallowed (eaten,
brewed as tea, or added
to other foods)

I

Possible Health Effects
Short-term

Hallucinations, altered perception of time, inability to tell fantasy from reality, panic, muscle
relaxation or weakness, problems with movement, enlarged pupils, nausea, vomiting,
drowsiness.

Long-term

Risk of flashbacks and memory problems.

Other Health-related
Issues

Risk of poisoning if a poisonous mushroom is accidentally used.

In Combination with
Alcohol

May decrease the perceived effects of alcohol.

Withdrawal
symptoms

Unknown.
Treatment Options

Medications

It is not known whether psilocybin is addictive. There are no FDA-approved medications to
treat addiction to psilocybin or other hallucinogens.

Behavioral Therapies

More research is needed to find out if psilocybin is addictive and whether behavioral
therapies can be used to treat addiction to this or other hallucinogens.
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Salvia
A dissociative drug that is an herb in the mint family native to southern Mexico, Salvia divinorum. Dissociative drugs
are hallucinogens that cause the user to feel detached from reality. For more information, see the Hallucinogens and
Dissociative Drugs Research Report.
Street Names
Magic mint, Maria
Pastora, Sally-D,
Shepherdess’s Herb,
Diviner’s Sage

Commercial Names
Sold legally in most
states as Salvia
divinorum.

Common Forms
Fresh or dried leaves

Common Ways Taken
Smoked, chewed, or
brewed as tea

DEA
Schedule
Not
Scheduled
(but
labeled
drug of
concern
by DEA
and illegal
in some
states)

Possible Health Effects
Short-term

Short-lived but intense hallucinations; altered visual perception, mood, body sensations;
mood swings, feelings of detachment from one’s body; sweating.

Long-term

Unknown.

Other Health-related
Issues

Unknown.

In Combination with
Alcohol

Unknown.

Withdrawal
Symptoms

Unknown.
Treatment Options

Medications

It is not known whether salvia is addictive. There are no FDA-approved medications to treat
addiction to salvia or other dissociative drugs.

Behavioral Therapies

More research is needed to find out if salvia is addictive, but behavioral therapies can be
used to treat addiction to dissociative drugs.
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Steroids (Anabolic)
Man-made substances used to treat conditions caused by low levels of steroid hormones in the body and abused to
enhance athletic and sexual performance and physical appearance. For more information, see the Anabolic Steroid
Abuse Research Report.
Street Names
Juice, Gym Candy,
Pumpers, Roids

Commercial Names
(Common)

Common Forms

Nandrolone
(Oxandrin®),
oxandrolone
(Anadrol®),
oxymetholone
(Winstrol®), stanozolol
(Durabolin®),
testosterone cypionate
(Depo-testosterone®)

Tablet, capsule, liquid
drops, gel, cream, patch,
injectable solution

Common Ways Taken

DEA
Schedule

Injected, swallowed,
applied to skin

III

Possible Health Effects
Short-term

Headache, acne, fluid retention (especially in the hands and feet), oily skin, yellowing of the
skin and whites of the eyes, infection at the injection site.

Long-term

Kidney damage or failure; liver damage; high blood pressure, enlarged heart, or changes in
cholesterol leading to increased risk of stroke or heart attack, even in young people;
aggression; extreme mood swings; anger (“roid rage”); paranoid jealousy; extreme
irritability; delusions; impaired judgment.

Other Health-related
Issues

Males: shrunken testicles, lowered sperm count, infertility, baldness, development of
breasts, increased risk for prostate cancer.
Females: Facial hair, male-pattern baldness, menstrual cycle changes, enlargement of the
clitoris, deepened voice.
Adolescents: Stunted growth.
Risk of HIV, hepatitis, and other infectious diseases from shared needles.

In Combination with
Alcohol

Increased risk of violent behavior.

Withdrawal
Symptoms

Mood swings; tiredness; restlessness; loss of appetite; insomnia; lowered sex drive;
depression, sometimes leading to suicide attempts.
Treatment Options

Medications

Hormone therapy

Behavioral Therapies

More research is needed to find out if behavioral therapies can be used to treat steroid
addiction.
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Synthetic Cannabinoids (“K2”/”Spice”)
A wide variety of herbal mixtures containing man-made cannabinoid chemicals related to THC in marijuana but often
much stronger and more dangerous. Sometimes misleadingly called “synthetic marijuana” and marketed as a
“natural,” "safe," legal alternative to marijuana. For more information, see the Spice (“Synthetic Marijuana”)
DrugFacts.
Street Names

Commercial Names

K2, Spice, Black
Mamba, Bliss, Bombay
Blue, Fake Weed, Fire,
Genie, Moon Rocks,
Skunk, Smacked,
Yucatan, Zohai

No commercial uses

Common Forms
Dried, shredded plant
material that looks like
potpourri and is
sometimes sold as
“incense”

Common Ways Taken

DEA
Schedule

Smoked, swallowed
(brewed as tea)

I

Possible Health Effects
Short-term

Increased heart rate; vomiting; agitation; confusion; hallucinations, anxiety, paranoia;
increased blood pressure and reduced blood supply to the heart; heart attack.

Long-term
Other Health-related
Issues

Unknown.
Use of synthetic cannabinoids has led to an increase in emergency room visits in certain
areas.

In Combination with
Alcohol

Unknown.

Withdrawal
Symptoms

Headaches, anxiety, depression, irritability.
Treatment Options

Medications

There are no FDA-approved medications to treat K2/spice addiction.

Behavioral Therapies

More research is needed to find out if behavioral therapies can be used to treat synthetic
cannabinoid addiction.
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Tobacco
Plant grown for its leaves, which are dried and fermented before use. For more information, see the
Tobacco/Nicotine Research Report.
Street Names
None

Commercial Names
Multiple brand names

Common Forms
cigarettes, cigars, bidis,
hookahs, smokeless
tobacco (snuff, spit
tobacco, chew)

Common Ways Taken
Smoked, snorted,
chewed, vaporized

DEA
Schedule
Not
Scheduled

Possible Health Effects
Short-term

Increased blood pressure, breathing, and heart rate.

Long-term

Greatly increased risk of cancer, especially lung cancer when smoked and oral cancers when
chewed; chronic bronchitis; emphysema; heart disease; leukemia; cataracts; pneumonia.

Other Health-related
Issues

Pregnancy: miscarriage, low birth weight, premature delivery, stillbirth, learning and
behavior problems.

In Combination with
Alcohol

Unknown.

Withdrawal
symptoms

Irritability, attention and sleep problems, increased appetite.
Treatment Options

Medications

Behavioral Therapies



Bupropion (Zyban®)



Varenicline (Chantix®)



Nicotine replacement (gum, patch, lozenge)



Cognitive-behavioral therapy (CBT)
Self-help materials
Mail, phone, and Internet quit resources
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Federal Trafficking Penalties for Schedules I, II, III, IV, and V (except Marijuana)
Schedule
II

Substance/Quantity
Cocaine
500-4999 grams mixture

II

Cocaine Base
28-279 grams mixture
Fentanyl
40-399 grams mixture
Fentanyl Analogue
10-99 grams mixture
Heroin
100-999 grams mixture
LSD
1-9 grams mixture
Methamphetamine
5-49 grams pure or
50-499 grams mixture

IV
I
I
I
II

II

PCP
10-99 grams pure or
100-999 grams mixture

Penalty
First Offense: Not less than
5 yrs. and not more than 40
yrs. If death or serious
bodily injury, not less than
20 yrs. or more than life.
Fine of not more than $5
million if an individual, $25
million if not an individual.
Second Offense: Not less
than 10 yrs. and not more
than life. If death or serious
bodily injury, life
imprisonment. Fine of not
more than $8 million if an
individual, $50 million if not
an individual.

Substance/Quantity
Cocaine
5 kilograms or more
mixture
Cocaine Base
280 grams or more mixture
Fentanyl
400 grams or more mixture
Fentanyl Analogue
100 grams or more mixture
Heroin
1 kilogram or more mixture
LSD
10 grams or more mixture
Methamphetamine
50 grams or more pure
or 500 grams or more
mixture
PCP
100 grams or more pure
or 1 kilogram or more
mixture

Penalty
First Offense: Not less than
10 yrs. and not more than
life. If death or serious
bodily injury, not less than
20 yrs. or more than life.
Fine of not more than $10
million if an individual, $50
million if not an individual.
Second Offense: Not less
than 20 yrs, and not more
than life. If death or serious
bodily injury, life
imprisonment. Fine of not
more than $20 million if an
individual, $75 million if not
an individual.
2 or More Prior Offenses:
Life imprisonment. Fine of
not more than $20 million if
an individual, $75 million if
not an individual.

Substance/Quantity
Any Amount Of Other Schedule I & II
Substances
Any Drug Product Containing Gamma
Hydroxybutyric Acid
Flunitrazepam (Schedule IV)
1 Gram

Penalty
First Offense: Not more that 20 yrs. If death or serious bodily injury, not less than 20 yrs.
or more than Life. Fine $1 million if an individual, $5 million if not an individual.

Any Amount Of Other Schedule III
Drugs

First Offense: Not more than 10 yrs. If death or serious bodily injury, not more that 15
yrs. Fine not more than $500,000 if an individual, $2.5 million if not an individual.

Any Amount Of All Other Schedule IV
Drugs (other than one gram or more
of Flunitrazepam)

Any Amount Of All Schedule V Drugs

Second Offense: Not more than 30 yrs. If death or serious bodily injury, life
imprisonment. Fine $2 million if an individual, $10 million if not an individual.

Second Offense: Not more than 20 yrs. If death or serious injury, not more than 30 yrs.
Fine not more than $1 million if an individual, $5 million if not an individual.
First Offense: Not more than 5 yrs. Fine not more than $250,000 if an individual, $1
million if not an individual.
Second Offense: Not more than 10 yrs. Fine not more than $500,000 if an individual, $2
million if other than an individual.
First Offense: Not more than 1 yr. Fine not more than $100,000 if an individual, $250,000
if not an individual.
Second Offense: Not more than 4 yrs. Fine not more than $200,000 if an individual,
$500,000 if not an individual.

Federal Trafficking Penalties for Marijuana, Hashish and Hashish Oil, Schedule I Substances
Marijuana
1,000 kilograms or more marijuana
mixture or 1,000 or more marijuana
plants

First Offense: Not less than 10 yrs. or more than life. If death or serious bodily injury, not
less than 20 yrs., or more than life. Fine not more than $10 million if an individual, $50
million if other than an individual.
Second Offense: Not less than 20 yrs. or more than life. If death or serious bodily injury,
life imprisonment. Fine not more than $20 million if an individual, $75 million if other than
an individual.
First Offense: Not less than 5 yrs. or more than 40 yrs. If death or serious bodily injury, not
less than 20 yrs. or more than life. Fine not more than $5 million if an individual, $25
million if other than an individual.

Marijuana
100 to 999 kilograms marijuana
mixture or 100 to 999 marijuana
plants

Marijuana
50 to 99 kilograms marijuana mixture,
50 to 99 marijuana plants
Hashish
More than 10 kilograms
Hashish Oil
More than 1 kilogram
Marijuana
less than 50 kilograms marijuana (but
does not include 50 or more marijuana
plants regardless of weight)

Second Offense: Not less than 10 yrs. or more than life. If death or serious bodily injury,
life imprisonment. Fine not more than $8 million if an individual, $50million if other than
an individual.
First Offense: Not more than 20 yrs. If death or serious bodily injury, not less than 20 yrs.
or more than life. Fine $1 million if an individual, $5 million if other than an individual.
Second Offense: Not more than 30 yrs. If death or serious bodily injury, life imprisonment.
Fine $2 million if an individual, $10 million if other than an individual.

First Offense: Not more than 5 yrs. Fine not more than $250,000, $1 million if other than
an individual.
Second Offense: Not more than 10 yrs. Fine $500,000 if an individual, $2 million if other
than individual.

1 to 49 marijuana plants
Hashish
10 kilograms or less
Hashish Oil
1 kilogram or less

Summary of Selected Ohio Drug and Alcohol Laws

Subject

Applicable Law

Alcohol

4301.62

Alcohol

4301.63

Alcohol

4301.634

Alcohol

4301.636

Alcohol

4301.62

Alcohol

4301.67

Alcohol

4301.69

Applies to/unlawful
to:
Open container of
alcohol in public
Purchase by minor
Misrepresentation by
minor to obtain alcohol
Furnishing false
identification cards
Consumption in motor
vehicle
Possession of alcohol
not lawfully acquired
Sale or furnishment to
minor

Penalty/Sentence
Up to $100 fine
Up to $1,000/
6 months
Up to $1,000 /
6 months
Up to $1,000/
6 months
Up to $250
30 days
Up to $250
30 days
$1,000
6 months

Marijuana

2925.03

Sale of: First offense

Marijuana

2925.03

Sale of: Second offense
or near school

Marijuana

2925.11

Possession or use
(<100 g)

$100 (mand.)
None

Marijuana

2925.11

Possession or use
(>100 g)

$250 (mand.)
0-30 days

Cocaine/Crack/Heroin/
Hashish/LSD
Cocaine/Crack/Heroin/
Hashish/LSD

2925.11

Possession or use First
Offense
Possession or use
Second offense

Cocaine/Crack/Heroin/
Hashish/LSD

2925.03

2925.11

Sale of: First offense

$1,000 (mand.)
1/2-5 years to
$5,000 (mand.)
2-15 years (depending
on amount)
$2,000 (mand.)
1-10 years to
$10,000 (mand.)
2-15 years (depending
on amount)

$1,500 (mand.) 1/2-5
years
$2,500 (mand.)
1-10 years
$2,500 (mand.)
1-10 years to
$7,500 (mand.)
15 years-life
(depending on amount)

Cocaine/Crack/Heroin/
Hashish/LSD

2925.03

All

2925.04

Sale of: Second offense
or near school

$5,000 (mand.)
2-15 years to
$15,000 (mand.)
20 years-life
(depending on amount)

Illegal manufacture of
drugs; illegal cultivation
of marihuana
Note: This summary is provided for informational purposes only and is not intended as legal advice.
The information contained herein is not warranted to be current or complete.
Summary of Selected New Hampshire Drug and Alcohol Laws

Subject
Alcohol

Citation
NH RSA 179:5

Alcohol

NH RSA 178:1

Alcohol

NH RSA 179:9

Falsely represent age if under 21..
Violation is a misdemeanor for first
offense, with a

Alcohol

NH RSA 179:10

Alcohol

NH RSA
265A:44

Possess any liquor or alcoholic
beverage, or be intoxicated by
consumption of an alcoholic beverage
(BAC .02% or more) if under 21.
Operate a motor vehicle in which open
containers of alcoholic beverages are
found, if under 21.

Alcohol/Drugs

Applies to/unlawful to:
Sell or give away any alcoholic beverage
to a person under the age of 21 or to
any intoxicated person regardless of
age.
Sale/exchange without a permit.

NH RSA 265-A:2 Operate a motor vehicle while under
the influence of alcohol or any
controlled drug or any combination of
alcohol and controlled drug. (BAC .08%
21 or over; .02% under 21).

Penalty/Sentence
Up to one year and/or
$2,000 fine

Up to 7 years and/or
$4,000 fine
Minimum fine $500;
second or subsequent
offense, minimum
$1,000.
First offense, minimum
$300; second offense,
minimum $600.
$150 fine and/or
suspension for 60 days
for a first offense; up to
one year for
subsequent offenses.
Minimum $500;
completion of
program; revocation of
90 days or more, and
possible required drug
or alcohol treatment.
NH RSA 265-A:18.
Penalties are more
stringent for
subsequent
convictions.

Illegal Drugs

Illegal Drugs

NH RSA 318B:26

Possess, manufacture, control, sell,
purchase, administer, transport,
dispense, possess with an intent to sell,
package or repackage any controlled
drug or controlled drug analog.

NH RSA 318-B:2 Deliver, possess with intent to deliver,
or manufacture with intent to deliver,
drug paraphernalia, knowing that it is
intended to be used to plant, grow,
harvest, manufacture, produce, process,

Penalties for this
offense vary according
to the nature and the
amount of the drug.
See NH RSA 318-B:26
for a list of all
penalties.
Up to one year in jail,
up to $2,000 fine.

prepare, test, analyze, pack, store,
conceal, ingest, inhale, or otherwise
introduce into the controlled substance
into the human body.
Note: This summary is provided for informational purposes only and is not intended as legal advice. The
information contained herein is not warranted to be current or complete.
Summary of Selected Washington Drug and Alcohol Laws

Subject
Alcohol

Citation
RCW 66.44

Alcohol

RCW 66.44

Alcohol

RCW 66.44

Alcohol

RCW 66.44

Applies to/unlawful to:
Persons under age 21 may not acquire,
possess, or consume alcohol. Nor may
other persons furnish alcohol to anyone
under 21 or permit underaged
consumption on premises within their
control. Penalty: Maximum $500 fine, 2
months’ imprisonment, or both.
Persons under age 21 may not be in a
public place or in a vehicle in public
while exhibiting the effects of having
consumed alcohol. A public place
includes city streets and any buildings
and grounds used for University
purposes.
Persons under 21 may not purchase or
attempt to purchase alcohol.
Alcohol may not be opened or
consumed in a public place.

Penalty/Sentence
Maximum $500 fine,
up to 2 months
imprisonment, or both.

Maximum $500 fine,
up to 2 months
imprisonment, or both.

Maximum $1,000 fine,
up to 90 days
imprisonment, or both.
Maximum $100 fine.

Motor Vehicle

RCW
46.61.502,
Seattle Mun.
Code 11.56.020

Driving under the influence.
(1) A person is guilty of driving while
under the influence of intoxicating
liquor, marijuana, or any drug if the
person drives a vehicle within this state:
(a) And the person has, within two
hours after driving, an alcohol
concentration of 0.08 or higher as
shown by analysis of the person's
breath or blood made under RCW
46.61.506; or
(b) The person has, within two hours
after driving, a THC concentration of
5.00 or higher as shown by analysis of
the person's blood made under RCW
46.61.506; or
(c) While the person is under the
influence of or affected by intoxicating
liquor, marijuana, or any drug; or
(d) While the person is under the
combined influence of or affected by
intoxicating liquor, marijuana, and any
drug.

Penalty may include
fines, incarceration and
suspension or loss of
license.
For BAC <.15%: 1-364
days’ incarceration,
fine $350-$5,000;
For BAC >.15%, 2-364
days’ incarceration,
fine of $500-$5,000.
Prior offenses and
refusal to submit to
test result in additional
penalties.

Alcohol/Drugs
Illegal Drugs

RCW 69.50

Illegal Drugs

RCW 69.50

It is unlawful to manufacture, deliver,
or possess an illicit drug.

Maximum $10,000
fine, 5 years
imprisonment, or both.
Penalty: Minimum
$250 fine and not less
than 24 hours in jail.

It is unlawful to possess or use drug
paraphernalia for purposes relating to
the manufacture, delivery, possession,
or use of an illicit drug.
Marijuana
RCW 69.50.445 It is unlawful to open a package
A person who violates
Seattle Mun.
containing marijuana, useable
this section is guilty of
Code
marijuana, or a marijuana-infused
a class 3 civil infraction
12A.20.100
product, or consume marijuana, useable under chapter 7.80
marijuana, or a marijuana-infused
RCW, with a default
product, in view of the general public.
fine of $50.
Note: This summary is provided for informational purposes only and is not intended as legal advice. The
information contained herein is not warranted to be current or complete.
Summary of Selected California Drug/Alcohol Laws

Subject
Illegal
Drugs

Illegal
Drugs

Illegal
Drugs

Controlled
Substances

Marijuana

Marijuana

Applies
Applicable Law
to/unlawful
to:
Cal. Health &
“unlawful
Safety Code
possession or
11054-11058
possession for
sale”
Cal. Health and “use or be
Safety Code
under the
11550
influence of a
controlled
substance”
Cal. Health and “possess,
Safety Code
furnish or
11362 et seq.
manufacture
drug
paraphernalia”
Cal. Health and “Unlawful
Safety Code
possession of
11377
controlled
substance”
Cal. Health and “possess,
Safety Code
cultivate, sell
11357, 11358, or possess for
11359
sale
marijuana”
Cal. Health and “possess
Safety Code
concentrated
11357
cannabis”

Penalty/Sentence

Penalties include fines, incarceration, rehabilitation
program, or combination thereof.

Penalties include fines, incarceration, rehabilitation
program, or combination thereof.

Penalties include fines, incarceration, rehabilitation
program, or combination thereof.

Penalties include fines, incarceration, rehabilitation
program, or combination thereof.

<28.5 g is a misdemeanor punishable by fine of up to
$100; >28.5 grams punishable by fine of up to $500, six
months in jail or both.

Up to one year imprisonment and fine of up to $500.

Alcohol

Cal. Penal
Code 647(f)

Motor
Vehicle

Cal. Vehicle
Code 23152

“be under the
influence of
alcohol in a
public place
and unable to
exercise care
for one's own
safety or that
of others”
“operate a
motor vehicle
while under
the influence
of alcohol or
other
intoxicants or

Misdemeanor; subject to fine.

First offense: fines up to $2,600, imprisonment up to
six months, driver’s license
suspension up to ten months and interlock ignition
device required in some counties.
Second offense: fines up to $2,800, imprisonment up to
one year, driver’s license
suspension up to two years and interlock ignition

with a blood
alcohol level
of .08% or
higher”

Motor
Vehicle

Drivers under
One year suspension, or one year delay in issuance.
the age of 21
found with
any
measurable
amount of
blood alcohol
(.01% or more)
Los Angeles
Unlawful to
Bath Salts
Misdemeanor , subject to fine.
Mun. Code
use or possess
46.20
bath salts
Note: This summary is provided for informational purposes only and is not intended as legal advice. The
information contained herein is not warranted to be current or complete.

.

Cal. Vehicle
Code 23140

device required.
3. Third offense: fines up to $18,000, imprisonment up
to one year driver’s license
suspension up to three years and interlock ignition
device required.
4. Refusal to submit to a blood alcohol content test:
driving privileges are suspended
for one year, for two years if there is a prior offense
within 10 years and for three years
with three or more offenses within 10 years.

